Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$378K Hold
1,044
0.26% 67
2026
Q1
$370K Buy
1,044
+8
+0.8% +$2.85K 0.3% 63
2025
Q4
$339K Buy
1,036
+45
+5% +$14.3K 0.29% 62
2025
Q3
$280K Hold
991
0.25% 75
2025
Q2
$277K Sell
991
-50
-5% -$14.2K 0.27% 67
2025
Q1
$319K Hold
1,041
0.33% 58
2024
Q4
$270K Buy
+1,041
New +$309K 0.26% 67

Other funds holding AMGN

Post Resch Tallon Group's AMGN Position: Q2 2026 in Review

Post Resch Tallon Group held its Amgen (AMGN) position steady in Q2 2026 at 1,044 shares worth $378K. The position accounts for 0.26% of the portfolio, ranked #67.

Post Resch Tallon Group first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,152 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Post Resch Tallon Group held 1,044 shares of Amgen worth $378K as of Q2 2026.
  • Post Resch Tallon Group left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.26% of Post Resch Tallon Group's portfolio in Q2 2026, its #67 holding.
  • Post Resch Tallon Group first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,152 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Post Resch Tallon Group's 13F filing for Q2 2026, filed 7 Jul 2026.